Business Wire
-
Celerion Achieves Milestone With CLIA Certification For Its Bioanalytical Laboratory, Expanding Capabilities In Clinical Trials And Diagnostic Testing
2/6/2024
Celerion, a leading clinical research organization, proudly announces its recent achievement of obtaining the Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art bioanalytical laboratory located in Lincoln, Nebraska.
-
Aegis Sciences Corporation Announces Its Adoption Of Self-Regulatory Standards For NPS Testing
2/5/2024
Nearly 107,000 Americans died from a drug overdose in 2021, according to the Centers for Disease Control and Prevention. More than 80,000 of those deaths (75 percent) were opioid-related and, of those, nearly 71,000 (88 percent) involved high-potency synthetic opioids.
-
Propelling Diagnostics And Life Sciences Innovation From Early Phase Research To The Clinic: Revvity Showcases Cutting-Edge Solutions At SLAS2024
2/2/2024
Revvity, Inc. is set to boldly unveil its new branding while showcasing more than 40 products from its life sciences and diagnostics portfolio at SLAS2024 to be held in Boston from February 3-7 in booth #408.
-
Hologic Announces First And Only FDA-Cleared Digital Cytology System – Genius Digital Diagnostics System
2/1/2024
Hologic, Inc. announced today that its new Genius Digital Diagnostics System with the Genius Cervical AI algorithm has received clearance from the U.S. Food and Drug Administration (FDA), making it the first and only FDA-cleared digital cytology system that combines deep-learning-based artificial intelligence (AI) with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells.
-
GE HealthCare Announces Prucka 3 Digital Amplifier As Next Generation Platform For Electrophysiology Innovation
1/31/2024
GE HealthCare announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias.
-
Genie Life Sciences Partners With Opentrons To Provide New Lab Execution Software For Opentrons Robots
1/30/2024
Genie Life Sciences, a provider of laboratory workflow execution software, has announced a partnership with Opentrons Labworks, Inc., a provider of open-source liquid handling robots, to bring a new user-friendly, robust, and agile software solution for operating Opentrons lab robots and modules.
-
Genome Insight Receives College Of American Pathologists Accreditation For Reliable Whole Genome Sequencing
1/29/2024
Genome Insight, a clinical laboratory, is proud to announce its accreditation by the College of American Pathologists (CAP) for its whole genome sequencing services.
-
Idengene SA To Bring Contextual Genomics’ Revolutionary Cancer Genomic Test Find-It To Brazil
11/9/2017
Brazilian diagnostics company Idengene SA has partnered with leading Canadian cancer genomics company Contextual Genomics to bring Find-It™, a potentially revolutionary genomic test, to Brazil. Idengene will offer Find-It™ at its laboratory in Brazil to patients diagnosed with cancer
-
New Benchtop Centrifuge Incorporates Hybrid Rotor For Application Flexibility
2/4/2016
Clinical and life science researchers can now benefit from a new benchtop centrifuge that features a unique 2-in-1 hybrid rotor that has interchangeable fixed-angle and swinging buckets to facilitate quick and convenient switching between applications
-
First Patient Enrolled In Dabigatran Study Comparing Anticoagulation Strategies During AF Ablation
5/13/2015
The first patient with atrial fibrillation (AF) has been enrolled in the global RE-CIRCUIT™ study.4 The study assesses the safety and efficacy of uninterrupted anticoagulation with dabigatran etexilate (Pradaxa®) during ablation procedures compared to warfarin.1 Results from the RE-CIRCUIT™ study are expected during 2016